NORTHSTAR DISTRIBUTION CENTER 8912 — Hydroxychloroquine Importer Profile
Pharmaceutical Importer · #2 buyer for Hydroxychloroquine · $1.7M import value · 35 shipments · UNITED STATES · DGFT Verified
NORTHSTAR DISTRIBUTION CENTER 8912 is the #2 importer of Hydroxychloroquine from India with $1.7M in import value and 35 verified shipments. NORTHSTAR DISTRIBUTION CENTER 8912 holds a 1.2% market share in Hydroxychloroquine imports based in UNITED STATES. The company sources from 2 verified suppliers across 14 formulations shipped to 1 country. Overall, NORTHSTAR DISTRIBUTION CENTER 8912 imports 35 pharmaceutical products worth $80.5M across 17 therapeutic categories.
NORTHSTAR DISTRIBUTION CENTER 8912 — Hydroxychloroquine Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Hydroxychloroquine to NORTHSTAR DISTRIBUTION CENTER 8912?
Verified from 35 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| ZYDUS LIFESCIENCES LIMITED | $1.6M | 33 | 94.1% |
| CADILA HEALTHCARE LIMITED | $100.0K | 2 | 5.9% |
NORTHSTAR DISTRIBUTION CENTER 8912 sources Hydroxychloroquine from 2 verified Indian suppliers based on 35 customs records. The primary supplier is ZYDUS LIFESCIENCES LIMITED accounting for 94.1% of imports.
How Does NORTHSTAR DISTRIBUTION CENTER 8912 Compare to Nearest Hydroxychloroquine Importers?
Buyers ranked immediately above and below #2 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | EVERSANA LIFE SCIENCE SERVICES | UNITED STATES | $10.0M | 200 | $50.0K |
| 3 | IPCA LABORATORIES UK LIMITED | UNITED KINGDOM | $2.6M | 55 | $47.9K |
| 2 | NORTHSTAR DISTRIBUTION CENTER 8912 ★ | UNITED STATES | $1.6M | 33 | $50.0K |
| 5 | EVERSANA LIFE SCIENCES SERVICES,LLC | UNITED STATES | $750.0K | 15 | $50.0K |
| 7 | HAPHARCO J.S.C. BRANCH | VIETNAM | $450.0K | 9 | $50.0K |
NORTHSTAR DISTRIBUTION CENTER 8912 ranks #2 among 271 Hydroxychloroquine importers from India. Average shipment value of $50.0K compared to the market average of $66.1K. The closest competitors by value are EVERSANA LIFE SCIENCE SERVICES and IPCA LABORATORIES UK LIMITED.
Where Does NORTHSTAR DISTRIBUTION CENTER 8912 Import Hydroxychloroquine To?
Destination countries from 35 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $1.7M | 35 | 100.0% |
NORTHSTAR DISTRIBUTION CENTER 8912 imports Hydroxychloroquine to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $1.7M.
What Hydroxychloroquine Formulations Does NORTHSTAR DISTRIBUTION CENTER 8912 Import?
| Formulation | Value | Shipments |
|---|---|---|
| PHARMACEUTICAL MEDICINE FOR HUMAN USE -HYDROXYCHLOROQUINE SULFATE TABLETS USP 200 MG - 1 X 500 | $320.0K | 7 |
| PHARMACEUTICAL MEDICINE FOR HUMAN USE -HYDROXYCHLOROQUINE SULFATE TABLETS USP 200 MG - 1 X 500NOS | $300.0K | 6 |
| PHARMACEUTICAL MEDICINE FOR HUMAN USE -HYDROXYCHLOROQUINE SULFATE TABLETS USP 200 MG - 1 X 100 | $239.1K | 5 |
| PHARMACEUTICAL MEDICINE FOR HUMAN USE- HYDROXYCHLOROQUINE SULFATE TABLETS USP 200 MG - 1 X 500 | $200.0K | 4 |
| PHARMACEUTICAL MEDICINE FOR HUMAN USE- HYDROXYCHLOROQUINE SULFATE TABLETS USP 200 MG - 1 X 100 | $150.0K | 3 |
| PHARMACEUTICAL MEDICINE FOR HUMAN USE HYDROXYCHLOROQUINE SULFATE TABLETS USP 200 MG 1 X 500 | $100.0K | 2 |
| HYDROXYCHLOROQUINE SULFATE TABLETS USP 200 MG - 1 X 500 - ECNONO# 2362408 B.NO M314175 AS PER INVOICE | $50.0K | 1 |
| PHARMACEUTICAL MEDICINE FOR HUMAN USE- HYDROXYCHLOROQUINE SULFATE TABLETS USP 200 MG - 1 X 500 ECNONO# 2362408 | $50.0K | 1 |
| PHARMACEUTICAL MEDICINE FOR HUMAN USE HYDROXYCHLOROQUINE SULFATE TABLETS USP 200MG-1X500-ECNONO# 2362408 AS PER INVOICE | $50.0K | 1 |
| PHARMACEUTICAL MEDICINE FOR HUMAN USE -HYDROXYCHLOROQUINE SULFATE TABLETS USP 200 MG - 1 X 100 - ECNONO# 3980851 | $50.0K | 1 |
NORTHSTAR DISTRIBUTION CENTER 8912 imports 14 distinct Hydroxychloroquine formulations from India. The top formulation is PHARMACEUTICAL MEDICINE FOR HUMAN USE -HYDROXYCHLOROQUINE SU with 7 shipments worth $320.0K.
Regulatory Requirements: Importing Hydroxychloroquine into United States
What NORTHSTAR DISTRIBUTION CENTER 8912 and other importers must comply with to import Hydroxychloroquine from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Hydroxychloroquine
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Hydroxychloroquine from India and How Much Does NORTHSTAR DISTRIBUTION CENTER 8912 Import?
India exported $17.9M worth of Hydroxychloroquine through 3,717 shipments from 163 suppliers to 86 countries, serving 271 buyers globally. NORTHSTAR DISTRIBUTION CENTER 8912 imports $1.7M of this total, accounting for 1.2% of India's Hydroxychloroquine exports with 35 shipments from UNITED STATES. This is verified from 35 customs shipment records covering 14 distinct formulations.
What Is the Average Order Value for NORTHSTAR DISTRIBUTION CENTER 8912's Hydroxychloroquine Imports?
NORTHSTAR DISTRIBUTION CENTER 8912's average Hydroxychloroquine order value is $48.8K per consignment, based on 35 shipments totaling $1.7M. NORTHSTAR DISTRIBUTION CENTER 8912 is based in UNITED STATES and ranks #2 among all Hydroxychloroquine importers from India by value. The company sources from 2 verified suppliers in India.
Who Supplies Hydroxychloroquine to NORTHSTAR DISTRIBUTION CENTER 8912?
NORTHSTAR DISTRIBUTION CENTER 8912 sources Hydroxychloroquine from 2 verified Indian suppliers: ZYDUS LIFESCIENCES LIMITED ($1.6M, 94.1%), CADILA HEALTHCARE LIMITED ($100.0K, 5.9%). This is based on 35 customs records.
How Does NORTHSTAR DISTRIBUTION CENTER 8912 Compare to Other Hydroxychloroquine Importers?
NORTHSTAR DISTRIBUTION CENTER 8912 ranks #2 among 271 Hydroxychloroquine importers from India with a 1.2% market share. The top 3 importers are EVERSANA LIFE SCIENCE SERVICES ($10.0M), IPCA LABORATORIES UK LIMITED ($2.6M), NORTHSTAR DISTRIBUTION CENTER 8912 ($1.6M). NORTHSTAR DISTRIBUTION CENTER 8912 processed 35 shipments from UNITED STATES.
What Other Antimalarial & Antiparasitic Products Does NORTHSTAR DISTRIBUTION CENTER 8912 Import?
NORTHSTAR DISTRIBUTION CENTER 8912 also imports these antimalarial & antiparasitic products. Each links to the detailed product page.
About NORTHSTAR DISTRIBUTION CENTER 8912
NORTHSTAR DISTRIBUTION CENTER 8912 imports 35 products worth $80.5M. Beyond Hydroxychloroquine, top products include Rosuvastatin, Omeprazole, Clopidogrel, Metoprolol, Amoxicillin. View the complete NORTHSTAR DISTRIBUTION CENTER 8912 profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Hydroxychloroquine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Hydroxychloroquine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: NORTHSTAR DISTRIBUTION CENTER 8912 matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as NORTHSTAR DISTRIBUTION CENTER 8912's capped import value divided by total capped export value for Hydroxychloroquine across all Indian exporters.
- 5.Verified Records: This page is backed by 35 individual customs records matching NORTHSTAR DISTRIBUTION CENTER 8912 importing Hydroxychloroquine, covering 14 formulations from 2 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 86+ countries, 271+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Hydroxychloroquine Import Data for NORTHSTAR DISTRIBUTION CENTER 8912
Access order-level details, pricing data, supplier connections, and competitive analysis for NORTHSTAR DISTRIBUTION CENTER 8912's Hydroxychloroquine imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
NORTHSTAR DISTRIBUTION CENTER 8912
Full Company Profile →
35 products · $80.5M total trade · 17 categories
NORTHSTAR DISTRIBUTION CENTER 8912 × Hydroxychloroquine
Verified from customs records
Company Overview
Top Products by NORTHSTAR DISTRIBUTION CENTER 8912
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for NORTHSTAR DISTRIBUTION CENTER 8912.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Hydroxychloroquine. For current order-level data, contact TransData Nexus.